What is the ideal treatment timing for bisphosphonate therapy?

OBG Management. 2017 November;29(11):

October 20, 2017|ObGyn

John T. Repke, MD

WHAT DOES THIS MEAN FOR PRACTICE?

Oral bisphosphonates remain in our armamentarium for reducing fracture in postmenopausal patients
Ideal duration of therapy remains unclear
Counsel patients: up to 2 y of therapy reduces fracture risk; >10 y of therapy may increase fracture risk

Citation: Drieling RL, LaCroix AZ, Beresford SA, et al. Long-term oral bisphosphonate therapy and fractures in older women: the Women’s Health Initiative. J Am Geriatr Soc. 2017;65(9):1924-1931.

,false